Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Boehringer Ingelheim
Federal Trade Commission
Baxter
Argus Health
Colorcon
US Department of Justice
Queensland Health
Harvard Business School

Generated: April 25, 2018

DrugPatentWatch Database Preview

LENTE ILETIN II Drug Profile

« Back to Dashboard

Which patents cover Lente Iletin Ii, and when can generic versions of Lente Iletin Ii launch?

Lente Iletin Ii is a drug marketed by Lilly and is included in two NDAs.

The generic ingredient in LENTE ILETIN II is insulin zinc susp purified pork. There are thirty-nine drug master file entries for this compound. Additional details are available on the insulin zinc susp purified pork profile page.
Summary for LENTE ILETIN II
US Patents:0
Applicants:1
NDAs:2
Clinical Trials: 1
Drug Prices:see details
DailyMed Link:LENTE ILETIN II at DailyMed
Drug patent expirations by year for LENTE ILETIN II

US Patents and Regulatory Information for LENTE ILETIN II

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly LENTE ILETIN II insulin zinc susp purified beef INJECTABLE;INJECTION 018477-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lilly LENTE ILETIN II (PORK) insulin zinc susp purified pork INJECTABLE;INJECTION 018347-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Accenture
Merck
Healthtrust
McKesson
Queensland Health
Cerilliant
Boehringer Ingelheim
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.